A First-in-human Study to Evaluate the Safety and Anticancer Effect of Several Doses of TH9619 in Patients with Advanced Cancer (ODIN).

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519639-40-00

Acronym

TH9619-0101

Enrollment

Registered

2025-04-11

Start date

2025-08-18

Completion date

Unknown

Last updated

2025-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

and Gastric Cancer (GC)), Colorectal Cancer (CRC), Solid tumors (including Non-Small Cell Lung Cancer (NSCLC), squamous cell carcinoma of the head and neck (HNSCC)

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

France, Spain

Outcome results